Alnylam Pharmaceuticals
ALNY
ALNY
560 hedge funds and large institutions have $33.4B invested in Alnylam Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 105 funds opening new positions, 217 increasing their positions, 170 reducing their positions, and 58 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
12% more call options, than puts
Call options by funds: $364M | Put options by funds: $325M
8% more funds holding
Funds holding: 518 → 560 (+42)
0.17% less ownership
Funds ownership: 94.73% → 94.55% (-0.17%)
Holders
560
Holding in Top 10
7
Calls
$364M
Puts
$325M
Top Buyers
| 1 | +$690M | |
| 2 | +$547M | |
| 3 | +$423M | |
| 4 |
Winslow Capital Management
Minneapolis,
Minnesota
|
+$264M |
| 5 |
OAG
Orbis Allan Gray
Hamilton,
Bermuda
|
+$150M |
Top Sellers
| 1 | -$346M | |
| 2 | -$315M | |
| 3 | -$122M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
-$97.2M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$94.4M |